AffRegInc.i
Curation
Accueil
Racine
Curation
Exploration
Accueil
Racine
Accueil
Racine

Serveur d'exploration Tocilizumab - Curation (Accueil)

Index « AffRegInc.i » - entrée « Fukuoka »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Fukuchiyama City Hospital < Fukuoka < Fukuoka  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 19.
Ident.Authors (with country if any)Title
000191 (2020) Yoshiya Tanaka [Japon] ; Hideto Kameda [Japon] ; Kazuyoshi Saito [Japon] ; Yuko Kaneko [Japon] ; Eiichi Tanaka [Japon] ; Shinsuke Yasuda [Japon] ; Naoto Tamura [Japon] ; Keishi Fujio [Japon] ; Takao Fujii [Japon] ; Toshihisa Kojima [Japon] ; Tatsuhiko Anzai [Japon] ; Chikuma Hamada [Japon] ; Yoshihisa Fujino [Japon] ; Shinya Matsuda [Japon] ; Hitoshi Kohsaka [Japon]Response to tocilizumab and work productivity in patients with rheumatoid arthritis: 2-year follow-up of FIRST ACT-SC study.
000324 (2020) Sae Ochi [Japon] ; Kazuyoshi Saito [Japon] ; Fumitaka Mizoguchi [Japon] ; Shigeaki Kato [Japon] ; Yoshiya Tanaka [Japon]Insensitivity versus poor response to tumour necrosis factor inhibitors in rheumatoid arthritis: a retrospective cohort study
000502 (2020) Kazuhisa Nakano [Japon] ; Kazuyoshi Saito [Japon] ; Aya Nawata [Japon] ; Kentaro Hanami [Japon] ; Satoshi Kubo [Japon] ; Ippei Miyagawa [Japon] ; Yoshihisa Fujino [Japon] ; Shingo Nakayamada [Japon] ; Yoshiya Tanaka [Japon]Clinical aspects in patients with rheumatoid arthritis complicated with lymphoproliferative disorders without regression after methotrexate withdrawal and treatment for arthritis after regression of lymphoproliferative disorders.
000D56 (2019) Masakazu Kondo [Japon] ; Hisakata Yamada [Japon]Drug survival rates of biological disease-modifying antirheumatic drugs and Janus kinase-inhibitor therapy in 801 rheumatoid arthritis patients: a 14 year-retrospective study from a rheumatology clinic in Japan.
000F17 (2019) Ayako Takaki-Kuwahara [Japon] ; Yojiro Arinobu [Japon] ; Kohta Miyawaki [Japon] ; Hisakata Yamada [Japon] ; Hirofumi Tsuzuki [Japon] ; Kensuke Irino [Japon] ; Masahiro Ayano [Japon] ; Yasutaka Kimoto [Japon] ; Hiroki Mitoma [Japon] ; Mitsuteru Akahoshi [Japon] ; Hiroshi Tsukamoto [Japon] ; Takahiko Horiuchi [Japon] ; Hiroaki Niiro [Japon] ; Koichi Akashi [Japon]CCR6+ group 3 innate lymphoid cells accumulate in inflamed joints in rheumatoid arthritis and produce Th17 cytokines
001399 (2018) Yukimi Otsuka [Japon] ; Chikako Kiyohara [Japon] ; Yusuke Kashiwado [Japon] ; Takuya Sawabe [Japon] ; Shuji Nagano [Japon] ; Yasutaka Kimoto [Japon] ; Masahiro Ayano [Japon] ; Hiroki Mitoma [Japon] ; Mitsuteru Akahoshi [Japon] ; Yojiro Arinobu [Japon] ; Hiroaki Niiro [Japon] ; Koichi Akashi [Japon] ; Takahiko Horiuchi [Japon]Effects of tumor necrosis factor inhibitors and tocilizumab on the glycosylated hemoglobin levels in patients with rheumatoid arthritis; an observational study.
001864 (2017) Shunsuke Mori [Japon] ; Tamami Yoshitama [Japon] ; Toshihiko Hidaka [Japon] ; Fumikazu Sakai [Japon] ; Mizue Hasegawa ; Yayoi Hashiba [Japon] ; Eiichi Suematsu [Japon] ; Hiroshi Tatsukawa [Japon] ; Akinari Mizokami [Japon] ; Shigeru Yoshizawa [Japon] ; Naoyuki Hirakata [Japon] ; Yukitaka Ueki [Japon]Comparative risk of hospitalized infection between biological agents in rheumatoid arthritis patients: A multicenter retrospective cohort study in Japan.
001A30 (2016) Shiho Fujiwara [Japon] ; Hiromi Mochinaga [Japon] ; Hirotomo Nakata [Japon] ; Koichi Ohshima [Japon] ; Masanori Matsumoto [Japon] ; Mitsuhiro Uchiba [Japon] ; Yoshiki Mikami [Japon] ; Hiroyuki Hata [Japon] ; Yutaka Okuno [Japon] ; Hiroaki Mitsuya [Japon] ; Kisato Nosaka [Japon]Successful treatment of TAFRO syndrome, a variant type of multicentric Castleman disease with thrombotic microangiopathy, with anti-IL-6 receptor antibody and steroids.
001D47 (2016) Akihiko Asahina [Japon] ; Takafumi Etoh [Japon] ; Atsuyuki Igarashi [Japon] ; Shinichi Imafuku [Japon] ; Hidehisa Saeki [Japon] ; Yoshiyuki Shibasaki [Japon] ; Yukiko Tomochika [Japon] ; Shigeyuki Toyoizumi [Japon] ; Makoto Nagaoka [Japon] ; Mamitaro Ohtsuki [Japon]Oral tofacitinib efficacy, safety and tolerability in Japanese patients with moderate to severe plaque psoriasis and psoriatic arthritis: A randomized, double‐blind, phase 3 study
001E94 (2015) Atsushi Ogata [Japon] ; Tatsuya Atsumi [Japon] ; Takaaki Fukuda [Japon] ; Yasuhiko Hirabayashi [Japon] ; Masaaki Inaba [Japon] ; Naoki Ishiguro [Japon] ; Motokazu Kai [Japon] ; Daisuke Kawabata [Japon] ; Daihei Kida [Japon] ; Hitoshi Kohsaka [Japon] ; Ryutaro Matsumura [Japon] ; Seiji Minota [Japon] ; Masaya Mukai [Japon] ; Takayuki Sumida [Japon] ; Kiyoshi Takasugi [Japon] ; Shigenori Tamaki [Japon] ; Tsutomu Takeuchi [Japon] ; Atsuhisa Ueda [Japon] ; Kazuhiko Yamamoto [Japon] ; Hisashi Yamanaka [Japon] ; Hajime Yoshifuji [Japon] ; Akira Nomura [Japon]Sustainable Efficacy of Switching From Intravenous to Subcutaneous Tocilizumab Monotherapy in Patients With Rheumatoid Arthritis.
002145 (2015) Shunsuke Mori [Japon] ; Mineharu Sugimoto [Japon]Pneumocystis jirovecii Pneumonia in Rheumatoid Arthritis Patients: Risks and Prophylaxis Recommendations
002295 (2014) Shunsuke Yamada [Japon] ; Akihiro Tsuchimoto [Japon] ; Yoshiki Kaizu [Japon] ; Masatomo Taniguchi [Japon] ; Kosuke Masutani [Japon] ; Hiroshi Tsukamoto [Japon] ; Hiroaki Ooboshi [Japon] ; Kazuhiko Tsuruya [Japon] ; Takanari Kitazono [Japon]Tocilizumab-induced remission of nephrotic syndrome accompanied by secondary amyloidosis and glomerulonephritis in a patient with rheumatoid arthritis.
002461 (2014) Yasuharu Nakashima [Japon] ; Masakazu Kondo [Japon] ; Hisaaki Miyahara [Japon] ; Yukihide Iwamoto [Japon]Drug delivery options to increase patient adherence and satisfaction in the management of rheumatoid arthritis -- focus on subcutaneous tocilizumab.
002574 (2014) Shuji Ohta [Japon] ; Tomomi Tsuru [Japon] ; Kimio Terao [Japon] ; Seiji Mogi [Japon] ; Midori Suzaki [Japon] ; Eisuke Shono [Japon] ; Yoshimasa Ishida [Japon] ; Eriko Tarumi [Japon] ; Masato Imai [Japon]Mechanism‐based approach using a biomarker response to evaluate tocilizumab subcutaneous injection in patients with rheumatoid arthritis with an inadequate response to synthetic DMARDs (MATSURI study)
002867 (2013) Tsutomu Takeuchi [Japon] ; Masayoshi Harigai [Japon] ; Yoshiya Tanaka [Japon] ; Hisashi Yamanaka [Japon] ; Naoki Ishiguro [Japon] ; Kazuhiko Yamamoto [Japon] ; Nobuyuki Miyasaka [Japon] ; Takao Koike [Japon] ; Minoru Kanazawa [Japon] ; Takuya Oba [Japon] ; Toru Yoshinari [Japon] ; Daniel Baker [États-Unis]Golimumab monotherapy in Japanese patients with active rheumatoid arthritis despite prior treatment with disease-modifying antirheumatic drugs: results of the phase 2/3, multicentre, randomised, double-blind, placebo-controlled GO-MONO study through 24 weeks
002F52 (2013) Takaaki Ogoshi [Japon] ; Takashi Kido [Japon] ; Kazuhiro Yatera [Japon] ; Keishi Oda [Japon] ; Toshinori Kawanami [Japon] ; Hiroshi Ishimoto [Japon] ; Noriho Sakamoto [Japon] ; Arisa Sano [Japon] ; Chiharu Yoshii [Japon] ; Shohei Shimajiri [Japon] ; Hiroshi Mukae [Japon]Assessment of Pathologically Diagnosed Patients with Castleman’s Disease associated with Diffuse Parenchymal Lung Involvement Using the Diagnostic Criteria for IgG4-Related Disease
003164 (2013) R. Nagamine [Japon] ; W. Chen [Japon]AB0424 Seasonal change may influence activity of rheumatoid arthritis
003D92 (2010) R. Yoshiki [Japon] ; M. Nakamura [Japon] ; Y. Tokura [Japon]Drug eruption induced by IL‐6 receptor inhibitor tocilizumab
003F19 (2009) Ryuji Nagamine [Japon] ; Weijia Chen ; Toshihiko Hara ; Keiichi Kondo ; Yoichi SugiokaImmediate reduction of white blood cell count after tocilizumab administration was observed in some cases.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/Main/Curation

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Curation/AffRegInc.i -k "Fukuoka" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Curation/AffRegInc.i  \
                -Sk "Fukuoka" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Curation/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    Main
   |étape=   Curation
   |type=    indexItem
   |index=    AffRegInc.i
   |clé=    Fukuoka
}}
Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021